The Management Board, chaired by TUM, comprises the lead scientists at all partner institutions, and two elected ESR representatives from the appointed PhD and postdocs & an associate researcher. This board will prepare all formal documents including the SMARTdrugs data Management Plan, IP Rights management plan, etc.. The board will oversee global financial management, scientific and financial reporting, and issues related to exploitation or licensing of the results. The board will make final decisions on communication strategies. In conjunction with our respective legal entities, and with input from the Scientific Advisory Team and our industrial partners, the Board will handle any potential conflicts of interest or disputation.

Proudly powered by WordPress